BiotechTube
Home/ImmunoScape/Alessandra Nardin, DVM
AN

Alessandra Nardin, DVM

Vice President, Strategy

ImmunoScape

Therapeutic Areas

Oncology

ImmunoScape Pipeline

DrugIndicationPhase
IS-001WT1‑positive solid tumorsPhase 1
CUE-102WT1‑positive tumors (booster)Phase 1

Leadership Team at ImmunoScape

MF
Michael Fehlings, PhD
Chief Executive Officer
RC
Romi Chandiramani, CA
Chief Financial Officer
TK
Tan Kar Wai, PhD
Vice President, Discovery and Preclinical Sciences
AB
Andrian Bot, MD/PhD
Chief Scientific Officer
View full ImmunoScape profile